DelRicht Research is proud to share that Dr. Patrick Dennis, Principal Investigator at Touro Medical Center in New Orleans, LA, is a featured author on three upcoming encore submissions of the abstract titled: “Co-administration of the adjuvanted respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) with the adjuvanted recombinant zoster vaccine (RZV) in adults ≥50 years of age.”

Presented initially at EuGMS 2024, this important work will now be showcased again through planned encore submissions at SIGG 2024, SIP 2024, and SIMIT 2024. The abstract highlights the potential for simultaneous administration of RSV and shingles vaccines, an approach that may help improve adult vaccine adherence and reduce clinical burden without compromising safety or immunogenicity.

Dr. Dennis’s continued leadership and involvement in vaccine research reinforce DelRicht Research’s commitment to advancing preventative care for aging populations. We’re proud to support our principal investigators like Dr. Patrick Dennis who are committed to moving medicine forward and look forward to seeing these encore presentations reach a broader audience at upcoming scientific meetings.